STOCK TITAN

TD SYNNEX CORP (SNX) SEC Filings, Oct 7-10, 2025

SNX NYSE

Welcome to our dedicated page for TD SYNNEX SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TD SYNNEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TD SYNNEX's regulatory disclosures and financial reporting.

Rhea-AI Summary

TD SYNNEX Corp filing a Form 144 notifies a proposed sale of 521 common shares held as restricted stock. The shares were acquired from the issuer on 10/03/2024 and the filing lists an aggregate market value of $81,263.03. The proposed sale is through Morgan Stanley Smith Barney LLC on 10/10/2025 on the NYSE. The filer reports no securities sold in the past three months and attests they are not aware of undisclosed material adverse information about the issuer. The filing supplies acquisition and payment details and identifies the broker and timing for the planned transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TD SYNNEX Corp. director and officer Dennis Polk reported multiple transactions on 10/09/2025. He exercised employee stock options to acquire 14,320 shares at an exercise price of $90.52 and 3,180 shares at $106.35, increasing option-derived holdings shown in Table II. Concurrently he sold a total of 17,500 common shares in several transactions at weighted average prices in ranges reported between $155.27 and $157.26 (detailed in the filing). After these transactions the filing shows 31,117 shares owned directly and 81,660 shares held indirectly by trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX Corporation disclosed supplemental indentures and forms for two series of senior notes as part of an 8-K filing dated October 10, 2025. The filing incorporates the original Indenture dated August 9, 2021 and adds a Sixth Supplemental Indenture and a Seventh Supplemental Indenture with Citibank, N.A. as trustee. The company included the form of 4.300% Senior Notes due 2029 and the form of 5.300% Senior Notes due 2035, along with an opinion and consent from Pillsbury Winthrop Shaw Pittman LLP. The filing also notes the interactive cover page XBRL tagging. This document outlines the legal instruments and note terms but does not state offering sizes, pricing, or use of proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Thompson Reyna, listed as President, North America and an officer of TD SYNNEX Corp (SNX), reported multiple dispositions of common stock on a Form 4. The filing shows a disposition of 58 shares on 10/07/2025 at a price of $158.65, and two additional dispositions on 10/08/2025 for 65 and 158 shares at a reported price of $0 for each line. The reported post-transaction beneficial ownership decreased from 12,525 shares to 12,302 shares following the transactions. The form includes an explanation stating: "Charitable donation of shares of common stock."

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX director and officer Dennis Polk reported a non-derivative sale of 870 shares of common stock on 10/07/2025 at a price of $158.65 per share. After the sale he directly beneficially owns 31,117 shares and indirectly owns 81,660 shares through a trust, showing continued significant aggregate holdings while executing a small disposition. The form was signed by an attorney-in-fact on 10/09/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TD SYNNEX Corp (SNX) Form 144 reports a proposed sale of 17,500 common shares through Morgan Stanley Smith Barney LLC on 10/09/2025, with an aggregate market value of $2,738,730.75. The filer states these shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists 81,437,855 shares outstanding, and shows recent disposals by the Polk Family Trust of 3,000 shares on each of 08/04/2025, 09/04/2025, and 10/06/2025 generating gross proceeds of $426,529.20, $445,486.80, and $477,258.30 respectively. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

TD SYNNEX Corporation filed an 8-K reporting an Underwriting Agreement relating to the Notes dated October 7, 2025. The agreement names several underwriters with BofA Securities, Inc., HSBC Securities (USA) Inc., Scotia Capital (USA) Inc. and Wells Fargo Securities, LLC acting as representatives. The filing is presented with an Inline XBRL cover page and is dated October 8, 2025. The document is signed by David Jordan, Executive Vice President and Chief Financial Officer. No further terms of the Notes (such as principal amount, interest rate, maturity, or expected use of proceeds) are included in the disclosed text.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
current report
-
Rhea-AI Summary

Thompson Reyna, President, North America and an officer of TD SYNNEX Corp. (SNX), reported sales of company common stock on 10/03/2025 and 10/06/2025

The filing shows three non-derivative sales totaling 560 shares, reducing direct beneficial ownership to 12,583 shares after transactions. Reported prices ranged from $157.84 to $158.66.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dennis Polk, a director and officer of TD SYNNEX Corp. (SNX), reported multiple sales of common stock executed on 10/06/2025 under a Rule 10b5-1 trading plan. The filing lists discrete disposals of 24, 1,276, 1,500, and 200 shares at weighted average prices between $157.92 and $160.96, with corresponding beneficial ownership balances reported as 84,636, 83,360, 81,860, and 81,660 shares (held indirectly by a trust). The form also records a larger disposal line showing 31,987 shares sold. The reporting person states the sales were effectuated pursuant to a 10b5-1 plan adopted on 10/13/2024 on behalf of the Polk family trust, where he serves as trustee. The form is signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Henry John Paul, the Chief Accounting Officer of TD SYNNEX Corp. (SNX), reported two open-market sales of company common stock. On 10/03/2025 he sold 173 shares at $158.66, reducing his holdings to 20,250 shares. On 10/06/2025 he sold 95 shares at $157.84, leaving 20,155 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many TD SYNNEX (SNX) SEC filings are available on StockTitan?

StockTitan tracks 159 SEC filings for TD SYNNEX (SNX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TD SYNNEX (SNX)?

The most recent SEC filing for TD SYNNEX (SNX) was filed on October 10, 2025.